171 related articles for article (PubMed ID: 30362496)
1. A biocompatible metal-organic framework as a pH and temperature dual-responsive drug carrier.
Lin W; Cui Y; Yang Y; Hu Q; Qian G
Dalton Trans; 2018 Nov; 47(44):15882-15887. PubMed ID: 30362496
[TBL] [Abstract][Full Text] [Related]
2. Fabrication of dopamine conjugated with protein @metal organic framework for targeted drug delivery: A biocompatible pH-Responsive nanocarrier for gemcitabine release on MCF‑7 human breast cancer cells.
Abd Al-Jabbar S; Atiroğlu V; Hameed RM; Guney Eskiler G; Atiroğlu A; Deveci Ozkan A; Özacar M
Bioorg Chem; 2022 Jan; 118():105467. PubMed ID: 34781115
[TBL] [Abstract][Full Text] [Related]
3. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
4. Morphology- and size-controlled synthesis of a metal-organic framework under ultrasound irradiation: An efficient carrier for pH responsive release of anti-cancer drugs and their applicability for adsorption of amoxicillin from aqueous solution.
Abazari R; Reza Mahjoub A; Slawin AMZ; Carpenter-Warren CL
Ultrason Sonochem; 2018 Apr; 42():594-608. PubMed ID: 29429708
[TBL] [Abstract][Full Text] [Related]
5. Zn(2+)-Triggered Drug Release from Biocompatible Zirconium MOFs Equipped with Supramolecular Gates.
Tan LL; Li H; Zhou Y; Zhang Y; Feng X; Wang B; Yang YW
Small; 2015 Aug; 11(31):3807-13. PubMed ID: 25919865
[TBL] [Abstract][Full Text] [Related]
6. Thermal Stimuli-Triggered Drug Release from a Biocompatible Porous Metal-Organic Framework.
Jiang K; Zhang L; Hu Q; Zhang Q; Lin W; Cui Y; Yang Y; Qian G
Chemistry; 2017 Jul; 23(42):10215-10221. PubMed ID: 28682004
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.
Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R
Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075
[TBL] [Abstract][Full Text] [Related]
8. Smart thermo/pH responsive magnetic nanogels for the simultaneous delivery of doxorubicin and methotrexate.
Salehi R; Rasouli S; Hamishehkar H
Int J Pharm; 2015 Jun; 487(1-2):274-84. PubMed ID: 25895723
[TBL] [Abstract][Full Text] [Related]
9. Construction of pH-sensitive lysozyme/pectin nanogel for tumor methotrexate delivery.
Lin L; Xu W; Liang H; He L; Liu S; Li Y; Li B; Chen Y
Colloids Surf B Biointerfaces; 2015 Feb; 126():459-66. PubMed ID: 25601095
[TBL] [Abstract][Full Text] [Related]
10. [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].
Vodovozova EL; Kuznetsova NR; Gaenko GP; Molotkovskiĭ IuG
Bioorg Khim; 2007; 33(4):470-3. PubMed ID: 17886439
[TBL] [Abstract][Full Text] [Related]
11. Outstanding Drug-Loading/Release Capacity of Hollow Fe-Metal-Organic Framework-Based Microcapsules: A Potential Multifunctional Drug-Delivery Platform.
Cui R; Zhao P; Yan Y; Bao G; Damirin A; Liu Z
Inorg Chem; 2021 Feb; 60(3):1664-1671. PubMed ID: 33434431
[TBL] [Abstract][Full Text] [Related]
12. Self-recognizing and stimulus-responsive carrier-free metal-coordinated nanotheranostics for magnetic resonance/photoacoustic/fluorescence imaging-guided synergistic photo-chemotherapy.
Tu L; Fan Z; Zhu F; Zhang Q; Zeng S; Chen Z; Ren L; Hou Z; Ye S; Li Y
J Mater Chem B; 2020 Jul; 8(26):5667-5681. PubMed ID: 32500886
[TBL] [Abstract][Full Text] [Related]
13. Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.
Leng X; Dong X; Wang W; Sai N; Yang C; You L; Huang H; Yin X; Ni J
Molecules; 2018 Sep; 23(10):. PubMed ID: 30274195
[TBL] [Abstract][Full Text] [Related]
14. A Y(III)-based Metal-Organic Framework as a Carrier in Chemodynamic Therapy.
Huang XJ; Yu SJ; Wang Y; Jin XK; Wang B; Gao LH; Zhu HL; Lin WX; Chen JJ
Inorg Chem; 2020 Dec; 59(23):17276-17281. PubMed ID: 33231077
[TBL] [Abstract][Full Text] [Related]
15. Metal-Organic Framework-Templated Biomaterials: Recent Progress in Synthesis, Functionalization, and Applications.
Begum S; Hassan Z; Bräse S; Wöll C; Tsotsalas M
Acc Chem Res; 2019 Jun; 52(6):1598-1610. PubMed ID: 30977634
[TBL] [Abstract][Full Text] [Related]
16. Targeted Drug Delivery in Covalent Organic Nanosheets (CONs) via Sequential Postsynthetic Modification.
Mitra S; Sasmal HS; Kundu T; Kandambeth S; Illath K; Díaz Díaz D; Banerjee R
J Am Chem Soc; 2017 Mar; 139(12):4513-4520. PubMed ID: 28256830
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition, drug load, and degradation studies of gelatin/methotrexate conjugates.
Ofner CM; Pica K; Bowman BJ; Chen CS
Int J Pharm; 2006 Feb; 308(1-2):90-9. PubMed ID: 16361072
[TBL] [Abstract][Full Text] [Related]
18. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery.
Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H
Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058
[TBL] [Abstract][Full Text] [Related]
19. Fullerenol-Based Intracellular Delivery of Methotrexate: A Water-Soluble Nanoconjugate for Enhanced Cytotoxicity and Improved Pharmacokinetics.
Bahuguna S; Kumar M; Sharma G; Kumar R; Singh B; Raza K
AAPS PharmSciTech; 2018 Apr; 19(3):1084-1092. PubMed ID: 29159749
[TBL] [Abstract][Full Text] [Related]
20. A Luminescent Amine-Functionalized Metal-Organic Framework Conjugated with Folic Acid as a Targeted Biocompatible pH-Responsive Nanocarrier for Apoptosis Induction in Breast Cancer Cells.
Abazari R; Ataei F; Morsali A; Slawin AMZ; L Carpenter-Warren C
ACS Appl Mater Interfaces; 2019 Dec; 11(49):45442-45454. PubMed ID: 31718155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
